Understanding how the tumor environment affects treatment response in T-cell lymphoma
Integrative Prediction of Therapeutic Response in T-cell Lymphoma by Omic and Spatial Modeling
This study is looking at how the arrangement of cells in T-cell lymphoma tumors affects how well treatments work, with the goal of finding new ways to personalize therapy for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11032024 on NIH RePORTER |
What this research studies
This research investigates the role of the tumor ecosystem in T-cell lymphoma, focusing on how the spatial organization of cells within tumors can influence treatment responses. By utilizing advanced imaging techniques and omics technologies, the study aims to identify new predictive biomarkers that can help tailor therapies for patients. The approach involves integrating detailed spatial data with existing genetic information to create more accurate models for predicting patient outcomes. This could lead to more personalized treatment strategies for individuals diagnosed with T-cell lymphoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with T-cell lymphoma who are seeking personalized treatment options.
Not a fit: Patients with other types of cancer or those not diagnosed with T-cell lymphoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better outcomes for patients with T-cell lymphoma.
How similar studies have performed: Other research has shown promise in using spatial modeling and omics technologies to improve cancer treatment predictions, indicating a potential for success in this approach.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Nirmal, Ajit Johnson — Brigham and Women's Hospital
- Study coordinator: Nirmal, Ajit Johnson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.